Article Versions Notes

Busse D, Simon P, Petroff D, Dorn C, Schmitt L, Bindellini D, Kratzer A, Dietrich A, Zeitlinger M, Huisinga W, et al. Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics. Pharmaceutics. 2021; 13(9):1380. https://doi.org/10.3390/pharmaceutics13091380

Busse, David, Philipp Simon, David Petroff, Christoph Dorn, Lisa Schmitt, Davide Bindellini, Alexander Kratzer, Arne Dietrich, Markus Zeitlinger, Wilhelm Huisinga, and et al. 2021. "Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics" Pharmaceutics 13, no. 9: 1380. https://doi.org/10.3390/pharmaceutics13091380

Busse, D., Simon, P., Petroff, D., Dorn, C., Schmitt, L., Bindellini, D., Kratzer, A., Dietrich, A., Zeitlinger, M., Huisinga, W., Michelet, R., Wrigge, H., & Kloft, C. (2021). Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics. Pharmaceutics, 13(9), 1380. https://doi.org/10.3390/pharmaceutics13091380